000 01596 a2200409 4500
005 20250514060124.0
264 0 _c20030401
008 200304s 0 0 eng d
022 _a0027-8424
024 7 _a10.1073/pnas.0437788100
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZhang, Meili
245 0 0 _aPretarget radiotherapy with an anti-CD25 antibody-streptavidin fusion protein was effective in therapy of leukemia/lymphoma xenografts.
_h[electronic resource]
260 _bProceedings of the National Academy of Sciences of the United States of America
_cFeb 2003
300 _a1891-5 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntibodies, Monoclonal
_xtherapeutic use
650 0 4 _aLeukemia
_xradiotherapy
650 0 4 _aLymphoma
_xradiotherapy
650 0 4 _aMice
650 0 4 _aRadioimmunotherapy
650 0 4 _aReceptors, Interleukin-2
_ximmunology
650 0 4 _aRecombinant Fusion Proteins
_ximmunology
650 0 4 _aStreptavidin
_ximmunology
650 0 4 _aTransplantation, Heterologous
700 1 _aZhang, Zhuo
700 1 _aGarmestani, Kayhan
700 1 _aSchultz, Jody
700 1 _aAxworthy, Donald B
700 1 _aGoldman, Carolyn K
700 1 _aBrechbiel, Martin W
700 1 _aCarrasquillo, Jorge A
700 1 _aWaldmann, Thomas A
773 0 _tProceedings of the National Academy of Sciences of the United States of America
_gvol. 100
_gno. 4
_gp. 1891-5
856 4 0 _uhttps://doi.org/10.1073/pnas.0437788100
_zAvailable from publisher's website
999 _c12367329
_d12367329